SCHEMBL14136334

SCHEMBL14136334

NNC(CC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.52
ATM Q13315 1/20 0.51
KMT2A Q03164 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MEN1 O00255 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
MAPK1 P28482 2/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
CES1 P23141 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4944942 0.83 GABBR2 (0.53) ATMALDH1A1L3MBTL1CYP2C19
SCHEMBL14327771 0.81 MEN1 (0.59) TSHRATMKMT2ASMN1; SMN2MEN1
SCHEMBL28007920 0.79 ALDH1A1 (0.55) TSHRATMKMT2ASMN1; SMN2MEN1
SCHEMBL17767291 0.78 KMT2A (0.57) TSHRATMKMT2ASMN1; SMN2MEN1
SCHEMBL17767290 0.78 KMT2A (0.57) TSHRATMKMT2ASMN1; SMN2MEN1
SCHEMBL3077522 0.77 TSHR (0.59) TSHRATMKMT2ASMN1; SMN2MEN1
SCHEMBL7050949 0.77 TSHR (0.59) TSHRATMKMT2ASMN1; SMN2MEN1
SCHEMBL6200667 0.77 TSHR (0.63) TSHRATMKMT2ASMN1; SMN2MEN1
SCHEMBL4943739 0.76 NAALAD2 (0.46) TSHRSMN1; SMN2ALDH1A1CYP1A2CYP2C19
SCHEMBL27197678 0.76 TSHR (0.58) TSHRATMKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012160447-A1 3, 5 -DIPHENYL- SUBSTITUTED PYRAZOLINES FOR THE TREATMENT OF CANCER, PROLIFERATIVE, INFLAMMATORY OR AUTOIMMUNE DISEASES DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-11-29 WO disclosed